Sarwer, director of the Center for Obesity Research and Education in the Barnett College of Public Health at Temple University, told Flow Space "A lot of these things can be multifactorial." With that said, here are seven unusual side effects of GLP-1 drugs
The full peer-reviewed data will be important, but it really does suggest that addressing obesity, alongside immune-targeted therapy, may improve outcomes
Clinical trials are continuing to assess its longer-term efficacy and safety across obesity, type 2 diabetes and other conditions
This article examines evidence-based guidance on when to initiate tirzepatide therapy for maximum benefit and safety
Many GLP-1 medications can lead to meaningful weight loss, which can, in turn, improve insulin resistance and blood sugar levels
D.AhujaP